| __timestamp | Genmab A/S | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 505679000 | 1271353000 |
| Thursday, January 1, 2015 | 487656000 | 1620577000 |
| Friday, January 1, 2016 | 660876000 | 2052295000 |
| Sunday, January 1, 2017 | 874278000 | 2075142000 |
| Monday, January 1, 2018 | 1431159000 | 2186100000 |
| Tuesday, January 1, 2019 | 2386000000 | 3036600000 |
| Wednesday, January 1, 2020 | 3137000000 | 2735000000 |
| Friday, January 1, 2021 | 4181000000 | 2908100000 |
| Saturday, January 1, 2022 | 5562000000 | 3592500000 |
| Sunday, January 1, 2023 | 7630000000 | 4439000000 |
| Monday, January 1, 2024 | 9748000000 | 5132000000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Regeneron Pharmaceuticals, Inc. and Genmab A/S have demonstrated significant commitment to R&D, with Genmab A/S showing a remarkable increase of over 1400% in their R&D expenses from 2014 to 2023. Regeneron, while starting with a higher base, has also increased its R&D spending by approximately 250% during the same period.
These investments highlight the strategic importance of R&D in driving the future of biotechnology.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Genmab A/S
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Blueprint Medicines Corporation
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
R&D Insights: How BeiGene, Ltd. and Genmab A/S Allocate Funds
United Therapeutics Corporation or Genmab A/S: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Genmab A/S vs Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Genmab A/S and BioCryst Pharmaceuticals, Inc.